Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.
Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves
Boston Scientific touts CMS reimbursement nod for asthma treatment | Regulatory Roundup
Boston Scientific Corp.’s (NYSE:BSX) Alair asthma management system won reimbursement from the Centers for Medicare & Medicaid Services, effective at the start of this year.
The Alair system delivers precise thermal energy lung to tissue via bronchoscope to reduce excessively smooth muscle, decreasing the airway’s ability to constrict.
Obama’s health care strategy: Thank the Republicans
MASSDEVICE ON CALL — Democrats are showing some gratitude toward Republican presidential hopefuls in a kill-them-with-kindness strategy some are calling a "death hug."
White House hopefuls Mitt Romney, the former governor of Massachusetts, and Indiana’s current chief, Gov. Mitch Daniels, both felt the squeeze this week as liberals invoked their names in praise of progress toward health care reform.
Boston Scientific agrees to pay a possible $444 million for Asthmatx Inc.
Boston Scientific Corp. (NYSE:BSX) inked a deal to spend $193.5 million in cash and possibly $250 million more on Asthmatx Inc.
MassDevice Network
@MassDevice
LinkedIn
Google+